Enable innovative and cost-effective trials by unlocking value through an improved bidding process, greater transparency, and investing in trusting partnerships
Sponsored by ClinEco, Global Clinical Trials Ecosystem and Marketplace
Learn how pharma, biotech, CROs, and vendors currently view the process of identifying and selecting outsourcing partners, and how they’d like to see it develop for better outcomes in the future. The pharma industry is facing ever-increasing challenges. Our trials are becoming more complex, requiring greater flexibility, and technology is changing at a fast pace. Now is the time to rethink our outsourcing models. Our dialogue needs to focus on outcomes and value generation rather than arguing over the small things that can stifle innovation. How confident are you with your current approach, and what are the risks and consequences of sticking with the status quo? This panel of experts from diverse backgrounds will explore how true value can be unlocked from collaborative partners. Key topics include:
1) Creating the right partnership and alliance culture to ensure the best outcome for both the sponsor and vendor
2) How procurement functions have adapted in defining and measuring value-based contracts
3) Incentivizing and rewarding innovation, and collectively owning a change in strategy.
AGENDA
Why is a standard competitive bidding process not working and what is a better framework?
Piet Theisohn, Vice President, Resource Management, Clinical Development & Operations, R&D Clinical Operations, Bayer AG – Pharma
How is value defined in strategic partnerships and alliances?
Jason Gubb, Co-Founder, ClinOpsClarity
Does the current process of vendor/outsourcing partner selection stifle innovation?
Luiz Barberini, Head, External Manufacturing Operations, Bayer SA
Are long-term vendor relationships in tune with the evolution of our Industry?
Eloise Moffett, Vice President, Commercial, Innovative Trials
Streamline vendor selection and uncover innovative and emerging companies to expand your clinical trial capabilities
Micah Lieberman, Co-Founder, VP, Community and Business Development, ClinEco
Privacy Policy